MBOT Stock Gains Following FDA Submission of the LIBERTY System
Microbot Medical Announces FDA Submission for the Commercialization of the LIBERTY Endovascular Robotic System
Microbot Medical CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access
Global Medical Service Robotics Market Project to Exceed $20 Billion in 2024 With Additional Growth Expected
Earnings Week Ahead: NVDA, WMT, SNOW, TGT, BIDU, NIO, ZIM, and More
マイクロボット・メディカル | 10-Q:Q3 2024 四半期報告書
Microbot Medical Stock Rises After Completing ACCESS-PVI Trial
Microbot Medical Accelerates Patient Enrollment of Its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up
Microbot Medical Advances Liberty Robotic System Telesurgery Innovation
Microbot Medical (MBOT) Inks New Phase 2 Agreement for LIBERTY
Microbot Medical Signs Phase 2 Collaboration Agreement With Corewell Health to Advance Remote Telesurgery Using the LIBERTY Endovascular Robotic System
Microbot Medical (MBOT) Gets Quality Certification for Its System
マイクロボット メディカル | 10-Q:Q2 2024 四半期報告書
Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization
Microbot Medical (MBOT) Inks Deal to Test Autonomous Robotics
Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY Endovascular Robotic Surgical System
Microbot Medical With The Addition Of Memorial Sloan Kettering Cancer Center Gets IRB Approval And Completes Enrollment Of Clinical Sites In Its Pivotal Human Clinical Trial
Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial With the Addition of Memorial Sloan Kettering Cancer Center
Microbot Medical (MBOT) Progresses in Its Human Clinical Trial
Baptist Hospital of Miami Completes First Clinical Procedure Using Microbot Medical's LIBERTY Endovascular Robotic Surgical System
このコンテンツを閲覧するにはログインが必要です。